pemafibrate
Kowa Pharmaceuticals
['venous thromboembolism']
 maybe but it s only looking at one section of the vasculature. the intervention still led to an inflammatory process elsewhere. from the abstract but pemafibrate was associated with a higher incidence of adverse renal events and venous thromboembolism . still clotting risks.
A nurse on the side of evidence based practice